Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 46861-46870 Newer>

The Motley Fool January 31, 2011 Brian Orelli	Pharma Goes Back to School But will it produce more drugs? The pharmaceutical industry is headed back to school, with a number of large drugmakers announcing partnerships with universities.
The Motley Fool January 31, 2011 Toby Shute	Chesapeake Produces Another Promising Partnership Once again, the firm's managed to secure a well-financed partner to help fund a big drilling play.
The Motley Fool January 31, 2011 Travis Hoium	Why I'm Not Buying Netflix Trends in revenue per customer and gross profit per customer are making Netflix a little less attractive.
The Motley Fool January 31, 2011 Christopher Barker	Alpha Nabs Massey in a Massive Coal Deal Alpha devours Massey to become top dog of U.S. met coal production.
The Motley Fool January 31, 2011 Jeremy Phillips	Time to Sell The Buckle? Let's decide if it's time to sell The Buckle, by evaluating its price, valuation, margins, and liquidity.
The Motley Fool January 31, 2011 Michael Olsen	3 Stocks I'm Watching One of these stocks will likely end up in the Rising Star Portfolio in the next month: Range Resources... SUPERVALU... Sanderson Farms...
The Motley Fool January 31, 2011 Jordan DiPietro	7 Cheap Material Stocks Paying Cold, Hard Cash These stocks are trading cheap and paying good dividends: BP Prudhoe Bay Royalty Trust... MV Oil Trust... EV Energy Partners LP... Pengrowth Energy... Cross Timbers Royalty... TransMontaigne Partners LP... Buckeye Partners LP...
The Motley Fool January 31, 2011 Andrew Bond	An Underfollowed Software Gem Some under-followed stocks like American Software present opportunities.
The Motley Fool January 31, 2011 Jordan DiPietro	7 Cheap Financial Stocks Paying Cold, Hard Cash These seven financial and real estate investment trust stocks are trading cheap and paying good dividends.
The Motley Fool January 31, 2011 Brian Orelli	5 Drugmakers Headed Back to the Drawing Board Sometimes an FDA rejection is more of a to-do list.
<Older 46861-46870 Newer> Return to current articles.